1 Comment
Jan 23Liked by Cardiology Trials

Finally! A “foundational” therapy of the era actually undergirded by a positive landmark trial result. And a methodology that selected patients who at least bear some resemblance to the “average” patients in today’s CCU.

I’ve been dismayed by what I perceive to be the rampant unconstrained vision among latter day guideline writers. I thought this was a relatively recent development. I thought guideline writers in the good ol’ days did better. Based on these reviews, I am no longer so sure about this sentiment.

Expand full comment